US 12,459,933 B2
Compounds and methods of use thereof as antibacterial agents
Brendan M. Crowley, Collegeville, PA (US); Philippe Nantermet, Lansdale, PA (US); David Olsen, Lansdale, PA (US); and Takao Suzuki, Shanghai (CN)
Assigned to Merck Sharp & Dohme LLC, Rahway, NJ (US)
Appl. No. 17/619,338
Filed by Merck Sharp & Dohme LLC, Rahway, NJ (US)
PCT Filed Jun. 2, 2020, PCT No. PCT/CN2020/093887
§ 371(c)(1), (2) Date Dec. 15, 2021,
PCT Pub. No. WO2021/000684, PCT Pub. Date Jan. 7, 2021.
Claims priority of application No. PCT/CN2019/094601 (WO), filed on Jul. 3, 2019.
Prior Publication US 2022/0235041 A1, Jul. 28, 2022
Int. Cl. C07D 413/14 (2006.01); A61K 31/422 (2006.01); A61K 31/437 (2006.01); A61K 31/541 (2006.01); A61K 45/06 (2006.01); A61P 31/06 (2006.01); A61P 31/08 (2006.01); C07D 413/10 (2006.01); C07D 413/12 (2006.01); C07D 417/10 (2006.01); C07D 471/04 (2006.01)
CPC C07D 413/14 (2013.01) [A61K 31/422 (2013.01); A61K 31/437 (2013.01); A61K 31/541 (2013.01); A61K 45/06 (2013.01); A61P 31/06 (2018.01); A61P 31/08 (2018.01); C07D 413/10 (2013.01); C07D 413/12 (2013.01); C07D 417/10 (2013.01); C07D 471/04 (2013.01)] 32 Claims
 
1. A compound, or a pharmaceutically acceptable salt thereof, having the structure:

OG Complex Work Unit Chemistry